NeoImmuneTech, Inc. (950220.KQ)
KRW 1126.0
(-3.6%)
KRW 1126.0
(-3.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 55.61 Billion | 58.18 Billion | 51.9 Billion | 31.26 Billion | 16.22 Billion |
| Selling, General and Administrative Expenses | 52.59 Billion | 36.98 Billion | 31.69 Billion | 3.2 Billion | 6.84 Billion |
| Research and Development Expenses | - | - | 38.42 Billion | 22.7 Billion | 8.59 Billion |
| Other Expenses | - | 18.52 Million | 15.46 Million | 354 Thousand | - |
| Cost and Expenses | 55.61 Billion | 58.18 Billion | 51.9 Billion | 31.26 Billion | 16.22 Billion |
| Operating Income | -55.61 Billion | -58.18 Billion | -51.9 Billion | -31.26 Billion | -16.22 Billion |
| Interest Expense | 225.28 Million | 261.39 Million | 219.15 Million | 185.79 Million | - |
| Income Tax Expense | 101.29 Million | 116.41 Million | 69.46 Million | 27.29 Million | 5.04 Million |
| Earnings before Tax | -53.3 Billion | -60.28 Billion | -52.41 Billion | -30.42 Billion | -14.19 Billion |
| Net Income | -53.4 Billion | -60.4 Billion | -52.48 Billion | -30.45 Billion | -14.19 Billion |
| Earnings Per Share Basic | -540.26 | -611.60 | -550.94 | -368.53 | -174.37 |
| Earnings Per Share Diluted | -540.26 | -611.60 | -550.94 | -368.52 | -174.37 |
| Weighted Average Shares Outstanding | 98.84 Million | 98.76 Million | 95.25 Million | 82.64 Million | 81.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 98.84 Million | 98.76 Million | 95.25 Million | 82.64 Million | 81.42 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -49.59 Billion | -57.15 Billion | -50.21 Billion | -29.4 Billion | - |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 9.68 Billion | 10.99 Billion | 55.61 Billion | 13.2 Billion | 13.41 Billion | 16.64 Billion |
| Selling, General and Administrative Expenses | 4.74 Billion | 5.01 Billion | - | 18.24 Billion | 2.79 Billion | 16.64 Billion |
| Research and Development Expenses | - | - | - | 31.1 Billion | 10.61 Billion | 20.48 Billion |
| Other Expenses | -357.37 Million | -536.02 Million | 23.06 Million | 272.19 Million | -36.54 Million | -211.19 Million |
| Cost and Expenses | 9.68 Billion | 10.99 Billion | 55.61 Billion | 13.2 Billion | 13.41 Billion | 16.64 Billion |
| Operating Income | -9.68 Billion | -10.99 Billion | -55.61 Billion | -13.2 Billion | -13.41 Billion | -16.64 Billion |
| Interest Expense | - | - | 225.28 Million | - | - | - |
| Income Tax Expense | 8.36 Million | 84.6 Million | 101.29 Million | -86.17 Million | 64.78 Million | 62.49 Million |
| Earnings before Tax | -9.99 Billion | -11.56 Billion | -53.3 Billion | -11.79 Billion | -13.05 Billion | -16.42 Billion |
| Net Income | -10 Billion | -11.65 Billion | -53.4 Billion | -11.7 Billion | -13.11 Billion | -16.48 Billion |
| Earnings Per Share Basic | -100.48 | -117.00 | - | -118.41 | -132.80 | -166.81 |
| Earnings Per Share Diluted | -100.48 | -117.00 | - | -118.41 | -132.69 | -166.79 |
| Weighted Average Shares Outstanding | 99.57 Million | 99.57 Million | 19.76 Million | 98.86 Million | 98.78 Million | 98.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.57 Million | 99.57 Million | 19.76 Million | 98.86 Million | 98.86 Million | 98.83 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -8.78 Billion | -10.15 Billion | - | -10.66 Billion | -13.41 Billion | -16.64 Billion |
| Earnings Before Tax Margin | - | - | - | - | - | - |
NIM
ELECTCAST
RBLBANK
MAITHANALL
5071
SABEVENTS